| Literature DB >> 35000583 |
Yan Liu1, Qiuyan Yu2, Haoyu Wen1, Fang Shi1, Fang Wang3, Yudi Zhao1, Qiumian Hong1, Chuanhua Yu4.
Abstract
OBJECTIVES: The purpose of this study is to describe the situation of COVID-19 in European countries and to identify important factors related to prevention and control.Entities:
Keywords: COVID-19; Europe; Lasso regression; Non-pharmaceutical interventions; Quantile regression
Mesh:
Year: 2022 PMID: 35000583 PMCID: PMC8743060 DOI: 10.1186/s13756-021-01039-x
Source DB: PubMed Journal: Antimicrob Resist Infect Control ISSN: 2047-2994 Impact factor: 4.887
Fig. 1a Changes of Rt in Finland under different prevention and control measures b Changes of Rt in Switzerland under different prevention and control measures
Fig. 2a The process of selecting variables in Lasso regression and b the process of selection variables in Lasso regression
Results of the quantile regression
| Quantiles | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 0.1 | 0.2 | 0.3 | 0.4 | 0.5 | 0.6 | 0.7 | 0.8 | 0.9 | |
| (Intercept) | − 3.88 | − 1.35 | − 14.06 | − 8.92 | − 11.81 | − 27.89 | − 25.56 | − 27.45 | − 3.62 |
| X1 | 0.12 | 0.05 | 0.11 | 0.01 | 0.18 | 0.10 | 0.01 | − 0.01 | 0.46 |
| X5 | 0.04 | 0.07* | 0.16* | 0.17* | 0.10* | 0.31* | 0.32* | 0.35 | 0.31 |
| X8 | − 0.21 | − 0.09 | − 0.44 | − 0.42* | − 0.52* | − 0.52 | − 0.69 | − 0.68 | − 0.51 |
| X14 | − 2.73 | − 3.36 | − 4.67 | − 5.39 | − 4.26 | 2.12 | − 0.39 | − 0.20 | − 28.64 |
| X16 | 4.32 | 6.44* | 5.12* | 5.15* | 8.30* | 6.51* | 8.81* | 12.12 | 17.33 |
| (Intercept) | − 8.54 | − 14.20 | 0.79 | − 8.84 | 35.08 | 15.56 | − 22.43 | − 17.87 | − 111.83 |
| X5 | 0.08 | 0.01 | − 0.04 | 0.09 | 0.19 | 0.23 | 0.54 | 0.74 | 1.44 |
| X6 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | − 0.01 | 0.00 |
| X8 | − 0.30 | − 0.69 | − 1.09* | − 0.86 | − 0.82* | − 1.28* | − 1.74* | − 1.47* | − 2.60* |
| X10 | 7.46 | 5.64 | 1.78 | 0.15 | 4.52 | 8.27 | − 4.70 | − 15.30 | − 33.26 |
| X13 | 3.83 | − 7.50 | − 57.16 | − 51.27 | − 48.17 | − 44.13 | − 31.18 | − 20.35* | 8.17 |
| X14 | − 6.59 | 7.77 | 39.84 | 41.69 | − 10.86 | − 6.85 | 1.25 | − 14.87* | 5.63 |
| X16 | 3.87 | 10.08* | 13.73* | 12.66* | 16.70* | 21.59* | 19.06* | 25.98 | 1.94 |
*The coefficient is statistically significant